×
About 2,500 results

ALLMedicine™ Bladder Dysfunction Center

Research & Reviews  841 results

Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury:...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858801
PloS One; Cotinat M, Boquet I et. al.

Jan 21st, 2023 - Satisfactory treatment is often lacking for spasticity, a highly prevalent motor disorder in patients with spinal cord injury (SCI). Low concentrations of riluzole potently reduce the persistent sodium current, the post-SCI increase in which contr...

A case report of autoimmune GFAP astrocytopathy presenting with abnormal heart rate var...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843977
BMC Neurology; Wen PY, Wang GQ et. al.

Jan 17th, 2023 - Autonomic dysfunctions including bladder dysfunction, gastrointestinal dysfunction and orthostasis are common symptoms of autoimmune glial fibrillary acidic protein astrocytopathy (A-GFAP-A); however, cardiac autonomic dysfunction and abnormal cir...

Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction
https://clinicaltrials.gov/ct2/show/NCT03987126

Jan 17th, 2023 - Spinal cord injury (SCI) is a life changing neurologic diagnosis that affects multiple body systems. Urinary tract infections (UTIs) are almost a universal complication of SCI with bladder dysfunction, and a significant cause of morbidity in those...

Genetic DAO Deficiency and Lower Urinary Tract Symptoms
https://clinicaltrials.gov/ct2/show/NCT05676346

Jan 11th, 2023 - Lower urinary tract symptoms (LUTS) encompass different symptoms and different causes, but their mechanism and etiology are not well defined. They have a high prevalence and cause discomfort and alter the quality of life. It has usually been consi...

NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
https://clinicaltrials.gov/ct2/show/NCT04977388

Jan 10th, 2023 - This pilot clinical trial will evaluate the safety, tolerability, dosing, and preliminary efficacy of Northera (Droxidopa) treatment in young adults who survived the major neurodegenerative and neurocognitive effects of Menkes disease through earl...

see more →

Guidelines  2 results

Design and Methodological Considerations of the Centers for Disease Control and Prevent...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201100
The Journal of Urology; Routh JC, Cheng EY et. al.

Oct 25th, 2016 - Care of children with spina bifida has significantly advanced in the last half century, resulting in gains in longevity and quality of life for affected children and caregivers. Bladder dysfunction is the norm in patients with spina bifida and may...

Clinical guideline for male lower urinary tract symptoms.
https://doi.org/10.1111/j.1442-2042.2009.02369.x
International Journal of Urology : Official Journal of Th... Homma Y, Araki I et. al.

Oct 9th, 2009 - This article is a shortened version of the clinical guideline for lower urinary tract symptoms (LUTS), which has been developed in Japan for symptomatic men aged 50 years and over irrespective of presumed diagnoses. The guideline was formed on the...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  104 results

Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction
https://clinicaltrials.gov/ct2/show/NCT03987126

Jan 17th, 2023 - Spinal cord injury (SCI) is a life changing neurologic diagnosis that affects multiple body systems. Urinary tract infections (UTIs) are almost a universal complication of SCI with bladder dysfunction, and a significant cause of morbidity in those...

Genetic DAO Deficiency and Lower Urinary Tract Symptoms
https://clinicaltrials.gov/ct2/show/NCT05676346

Jan 11th, 2023 - Lower urinary tract symptoms (LUTS) encompass different symptoms and different causes, but their mechanism and etiology are not well defined. They have a high prevalence and cause discomfort and alter the quality of life. It has usually been consi...

NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
https://clinicaltrials.gov/ct2/show/NCT04977388

Jan 10th, 2023 - This pilot clinical trial will evaluate the safety, tolerability, dosing, and preliminary efficacy of Northera (Droxidopa) treatment in young adults who survived the major neurodegenerative and neurocognitive effects of Menkes disease through earl...

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention
https://clinicaltrials.gov/ct2/show/NCT05269667

Dec 19th, 2022 - Neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorder (NMOSD) are severe demyelinating inflammatory autoimmune neurological disorders. The estimated global pooled prevalence of NMOSD is 1.82 per 100 000 people (Etemadifar et al. 20...

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
https://clinicaltrials.gov/ct2/show/NCT00354835

Dec 14th, 2022 - PRIMARY OBJECTIVES: I. To compare the early response rates, failure-free survival (FFS), and survival of patients with intermediate-risk rhabdomyosarcoma (RMS) treated with surgery, radiotherapy, and vincristine (vincristine sulfate), dactinomycin...

see more →

News  47 results

Decline in ambulatory function
https://www.mdedge.com/multiple-sclerosis-challenge-center/article/259558/multiple-sclerosis/decline-ambulatory-function

Nov 18th, 2022 - Based on this patient's history and presentation, the likely diagnosis is primary progressive multiple sclerosis (PPMS). PPMS represents around 10% of MS cases and tends to develop about a decade later than relapsing MS.

Botulinum toxin for chronic pain: What's on the horizon?
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM

Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.

Lesions in Pelvis May Be 'Tip of the Iceberg' in Endometriosis
https://www.medscape.com/viewarticle/951463

May 19th, 2021 - Recognizing the systemic effects of endometriosis may help doctors better understand the experiences of patients with the disease and guide the approach to diagnosis and treatment, according to the president of the American Society for Reproductiv...

Lesions in pelvis may be ‘tip of the iceberg’ in endometriosis
https://www.mdedge.com/obgyn/article/240279/endometriosis/lesions-pelvis-may-be-tip-iceberg-endometriosis
Jake Remaly

May 18th, 2021 - Recognizing the systemic effects of endometriosis may help doctors better understand the experiences of patients with the disease and guide the approach to diagnosis and treatment, according to the president of the American Society for Reproductiv.

FDA Approves Myrbetriq to Treat Pediatric NDO
https://www.medscape.com/viewarticle/948305

Mar 29th, 2021 - The US Food and Drug Administration (FDA) has expanded the indication for Mirabegron (Myrbetriq/Myrbetriq Granules) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurologic impairment, in children aged 3 years a...

see more →

Patient Education  1 results see all →